(Q36966608)

17 August 2017

1 reference

title

Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism? (English)

1 reference

17 August 2017

M Shawkat Razzaque

1

1 reference

17 August 2017

publication date

9 October 2007

1 reference

Nature Clinical Practice Endocrinology and Metabolism

17 August 2017

published in

1 reference

17 August 2017

volume

3

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

788-789

1 reference

The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

How fibroblast growth factor 23 works

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

Klotho converts canonical FGF receptor into a specific receptor for FGF23

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0667

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0667

1 reference

release_haqid72urneebo74pbhasnpcuy

17 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/haqid72urneebo74pbhasnpcuy

24 November 2022

mapped directly with Wikidata item

1 reference